Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis C

Free Subscription Articles published in J Med Virol Retrieve available abstracts of 107 articles: HTML format Text format

Single Articles

February 2010
1. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
   Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.
   J Med Virol. 2010;82:575-582.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. MEFFRE C , Le Strat Y, Delarocque-Astagneau E, Dubois F, et al
   Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: Social factors are important predictors after adjusting for known risk factors.
   J Med Virol. 2010;82:546-555.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LEE S , Watson MW, Flexman JP, Cheng W, et al
   Increased proportion of the CD56(bright) NK cell subset in patients chronically infected with hepatitis C virus (HCV) receiving interferon-alphaand ribavirin therapy.
   J Med Virol. 2010;82:568-574.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. CANTALOUBE JF , Gallian P, Bokilo A, Jordier F, et al
   Analysis of hepatitis C virus strains circulating in Republic of the Congo.
   J Med Virol. 2010;82:562-567.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SHIOGAMA K , Teramoto H, Morita Y, Mizutani Y, et al
   Hepatitis C virus infection in a Japanese leprosy sanatorium for the past 67 years.
   J Med Virol. 2010;82:556-561.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. ANTONELLI A , Ferri C, Ferrari SM, Ghiri E, et al
   High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia.
   J Med Virol. 2010;82:297-303.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
7. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
   Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.
   J Med Virol. 2010;82:390-395.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
8. ALMROTH G , Ekermo B, Akerlind B, Mansson AS, et al
   Monitoring hepatitis C infection in a major Swedish nephrology unit and molecular resolution of a new case of nosocomial transmission.
   J Med Virol. 2009;82:249-256.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. AKKARATHAMRONGSIN S , Praianantathavorn K, Hacharoen N, Theamboonlers A, et al
   Geographic distribution of hepatitis C virus genotype 6 subtypes in Thailand.
   J Med Virol. 2009;82:257-262.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. DEMETRIOU VL , van de Vijver DA, Hezka J, Kostrikis LG, et al
    Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    J Med Virol. 2009;82:263-270.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. ZHU Z , Wilson AT, Gopalakrishna K, Brown KE, et al
    Hepatitis C virus core protein enhances Telomerase activity in Huh7 cells.
    J Med Virol. 2009;82:239-248.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. VIAZOV S , Ross SS, Kyuregyan KK, Timm J, et al
    Hepatitis C virus recombinants are rare even among intravenous drug users.
    J Med Virol. 2009;82:232-238.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
13. LEE YM , Lin HJ, Chen YJ, Lee CM, et al
    Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form_2b6w.
    J Med Virol. 2009;82:57-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. FALASCA K , Ucciferri C, Mancino P, Gorgoretti V, et al
    Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response.
    J Med Virol. 2009;82:49-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KOBAYASHI M , Akuta N, Suzuki F, Hosaka T, et al
    Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.
    J Med Virol. 2009;82:41-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
16. BOUZGARROU N , Hassen E, Mahfoudh W, Gabbouj S, et al
    NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/Ribavirin therapy.
    J Med Virol. 2009;81:2021-2028.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ZAMPINO R , Marrone A, Merola A, Trani B, et al
    Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth.
    J Med Virol. 2009;81:2012-2020.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. LEGRAND-ABRAVANEL F , Colson P, Leguillou-Guillemette H, Alric L, et al
    Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
    J Med Virol. 2009;81:2029-2035.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. WANG C , Heim A, Schlaphoff V, Suneetha PV, et al
    Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
    J Med Virol. 2009;81:2079-2088.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. NDONGO N , Rechoum Y, De Sequeira S, Zoulim F, et al
    Inhibition of the binding of HCV serum particles to human hepatocytes by E1E2-specific D32.10 monoclonal antibody.
    J Med Virol. 2009;81:1726-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. WU KT , Chung KM, Feng IC, Sheu MJ, et al
    Acute hepatitis E virus infection in Taiwan 2002-2006 revisited: PCR shows frequent co-infection with multiple hepatitis viruses.
    J Med Virol. 2009;81:1734-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
22. LIN L , Libbrecht L, Verbeeck J, Verslype C, et al
    Quantitation of replication of the HCV genome in human livers with end-stage cirrhosis by strand-specific real-time RT-PCR assays: Methods and clinical relevance.
    J Med Virol. 2009;81:1569-1575.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. CHENG JC , Yeh YJ, Pai LM, Chang ML, et al
    293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.
    J Med Virol. 2009;81:1560-1568.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. MAKHZANGY HE , Esmat G, Said M, Elraziky M, et al
    Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4.
    J Med Virol. 2009;81:1576-1583.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
    Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C.
    J Med Virol. 2009;81:1584-1590.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
26. TODA T , Mitsui T, Tsukamoto Y, Ebara T, et al
    Molecular analysis of transmission of hepatitis C virus in a nurse who acquired acute hepatitis C after caring for a viremic patient with epistaxis.
    J Med Virol. 2009;81:1363-1370.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. ALZAHRANI AJ , Cruz DM, Obeid OE, Bukhari HA, et al
    Molecular detection of hepatitis B, hepatitis C, and torque teno viruses in drug users in Saudi Arabia.
    J Med Virol. 2009;81:1343-1347.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. TOYODA H , Kumada T, Kiriyama S, Sone Y, et al
    Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
    J Med Virol. 2009;81:1354-1362.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. CAVLEK TV , Margan IG, Lepej SZ, Kolaric B, et al
    Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.
    J Med Virol. 2009;81:1348-1353.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
30. ASKAR E , Bregadze R, Mertens J, Schweyer S, et al
    TLR3 gene polymorphisms and liver disease manifestations in chronic hepatitis C.
    J Med Virol. 2009;81:1204-1211.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. KHAN A , Tanaka Y, Azam Z, Abbas Z, et al
    Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.
    J Med Virol. 2009;81:1189-1197.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. NIU Y , Komatsu N, Komohara Y, Matsueda S, et al
    A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
    J Med Virol. 2009;81:1232-1240.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. KAGEYAMA S , Agdamag DM, Alesna ET, Abellanosa-Tac-An IP, et al
    Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the Philippines.
    J Med Virol. 2009;81:1157-1162.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. QUARANTINI LC , Miranda-Scippa A, Batista-Neves S, Powell VB, et al
    A neuropsychological study comparing patients infected with HCV and HBV without psychiatric comorbidities.
    J Med Virol. 2009;81:1184-1188.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. ARAUJO FM , Machado-Lima A, Durham AM, Teixeira R, et al
    Sequence and structural analysis of the 5' noncoding region of hepatitis C virus in patients with chronic infection.
    J Med Virol. 2009;81:1212-1219.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. MAIA LP , Martins-Filho OA, Teixeira-Carvalho A, Speziali E, et al
    Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis.
    J Med Virol. 2009;81:1220-1231.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. CASTILLO I , Bartolome J, Quiroga JA, Barril G, et al
    Hepatitis C virus infection in the family setting of patients with occult hepatitis C.
    J Med Virol. 2009;81:1198-1203.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
38. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
    Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.
    J Med Virol. 2009;81:1032-1039.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. PIZZILLO P , Almasio PL, Ferraro D, Craxi A, et al
    HCV genotypes in Sicily: Is there any evidence of a shift?
    J Med Virol. 2009;81:1040-1046.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. ELKADY A , Tanaka Y, Kurbanov F, Sugauchi F, et al
    Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication.
    J Med Virol. 2009;81:1015-1023.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. ENDO T , Fujimoto K, Nishio M, Yamamoto S, et al
    Case report: Clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus.
    J Med Virol. 2009;81:979-982.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. TAMORI A , Hayashi T, Shinzaki M, Kobayashi S, et al
    Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
    J Med Virol. 2009;81:1009-1014.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. SHEBL FM , El-Kamary SS, Saleh DA, Abdel-Hamid M, et al
    Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages.
    J Med Virol. 2009;81:1024-1031.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. CHU FY , Chiang SC, Su FH, Chang YY, et al
    Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    J Med Virol. 2009;81:973-978.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
45. INDOLFI G , Resti M
    Perinatal transmission of hepatitis C virus infection.
    J Med Virol. 2009;81:836-843.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. RYU SH , Fan X, Xu Y, Elbaz T, et al
    Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt.
    J Med Virol. 2009;81:844-847.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. KOSKINAS J , Zacharakis G, Sidiropoulos J, Elefsiniotis J, et al
    Granulocyte colony stimulating factor in HCV genotype-1 patients who develop Peg-IFN-alpha2b related severe neutropenia: A preliminary report on treatment, safety and efficacy.
    J Med Virol. 2009;81:848-852.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. OHKAWA K , Takehara T, Kato M, Kanada A, et al
    Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.
    J Med Virol. 2009;81:798-806.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. HAYASHI K , Katano Y, Honda T, Ishigami M, et al
    Mutations in the interferon sensitivity-determining region of hepatitis C virus genotype 2a correlate with response to pegylated-interferon-alpha 2a monotherapy.
    J Med Virol. 2009;81:459-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. CHANG ML , Chen TH, Chang MY, Yeh CT, et al
    Cell cycle perturbation in the hepatocytes of HCV core transgenic mice following common bile duct ligation is associated with enhanced p21 expression.
    J Med Virol. 2009;81:467-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. AKUTA N , Suzuki F, Hirakawa M, Kawamura Y, et al
    A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response.
    J Med Virol. 2009;81:452-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. CARPENTIER A , Conti F, Carriere M, Aoudjehane L, et al
    Analysis of gene transcription in sera during chronic hepatitis C infection.
    J Med Virol. 2009;81:473-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
    Long-term follow-up of patients with hepatitis C with a normal alanine aminotransferase.
    J Med Virol. 2009;81:446-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
54. MORI N , Imamura M, Kawakami Y, Saneto H, et al
    Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy.
    J Med Virol. 2009;81:640-649.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. CUEVAS JM , Torres-Puente M, Jimenez-Hernandez N, Bracho MA, et al
    Combined therapy of interferon plus ribavirin promotes multiple adaptive solutions in hepatitis C virus.
    J Med Virol. 2009;81:650-656.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. INOKUCHI M , Ito T, Uchikoshi M, Shimozuma Y, et al
    Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C.
    J Med Virol. 2009;81:619-627.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. LI CS , Chan PK, Tang JW
    Molecular epidemiology of hepatitis C genotype 6a from patients with chronic hepatitis C from Hong Kong.
    J Med Virol. 2009;81:628-633.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. SEME K , Vrhovac M, Mocilnik T, Maticic M, et al
    Hepatitis C virus genotypes in 1,504 patients in Slovenia, 1993-2007.
    J Med Virol. 2009;81:634-639.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. VERDICHIO-MORAES CF , Toralles-Pereira C, Grotto RM, Silva GF, et al
    Allelic frequencies of HPA-1 to 5 human platelet antigens in patients infected with hepatitis C virus.
    J Med Virol. 2009;81:757-759.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. CHEHADEH W , Al-Nakib W
    Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    J Med Virol. 2009;81:610-618.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
61. ZARIFE MA , Reis EA, Carmo TM, Lopes GB, et al
    Increased frequency of CD56(Bright) NK-cells, CD3(-)CD16(+)CD56(-) NK-cells and activated CD4(+)T-cells or B-cells in parallel with CD4(+)CDC25(High) T-cells control potentially viremia in blood donors with HCV.
    J Med Virol. 2009;81:49-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
62. DEMETRIOU VL , van de Vijver DA, Kostrikis LG
    Molecular epidemiology of hepatitis C infection in cyprus: Evidence of polyphyletic infection.
    J Med Virol. 2008;81:238-248.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. ROSS RS , Viazov S, Khudyakov YE, Xia GL, et al
    Transmission of hepatitis C virus in an orthopedic hospital ward.
    J Med Virol. 2008;81:249-257.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SHARKAWI FZ , Chudy M, Hanschmann KM, Kress J, et al
    Consistency of quantitation of HCV genotype 4 from egypt across three HCV-RNA amplification assays.
    J Med Virol. 2008;80:2086-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. NJOUOM R , Sartre MT, Timba I, Nerrienet E, et al
    Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C.
    J Med Virol. 2008;80:2079-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
66. MEIER V , Mihm S, Ramadori G
    Interferon-alpha therapy does not modulate hepatic expression of classical type I interferon inducible genes.
    J Med Virol. 2008;80:1912-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
67. FALASCA K , Ucciferri C, Mancino P, Vitacolonna E, et al
    Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection.
    J Med Virol. 2008;80:1900-1906.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. INDOLFI G , Bartolini E, Azzari C, Becciolini L, et al
    Intrafamilial transmission of hepatitis C virus: Infection of the father predicts the risk of perinatal transmission.
    J Med Virol. 2008;80:1907-1911.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
69. CANTALOUBE JF , Gallian P, Laperche S, Elghouzzi MH, et al
    Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors.
    J Med Virol. 2008;80:1732-1739.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. FERRARO D , Genovese D, Argentini C, Giordano V, et al
    Phylogenetic reconstruction of HCV genotype 1b dissemination in a small city centre: The Camporeale model.
    J Med Virol. 2008;80:1723-1731.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. XIA X , Zhao W, Tee KK, Feng Y, et al
    Complete genome sequencing and phylogenetic analysis of HCV isolates from China reveals a new subtype, designated 6u.
    J Med Virol. 2008;80:1740-1746.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. OH HB , Kim SO, Cha CH, Hong SP, et al
    Identification of hepatitis C virus genotype 6 in Korean patients by analysis of 5' untranslated region using a matrix assisted laser desorption/ionization time of flight-based assay, restriction fragment mass polymorphism.
    J Med Virol. 2008;80:1712-1719.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. LIN A , Thadareddy A, Goldstein MJ, Lake-Bakaar G, et al
    Immune suppression leading to hepatitis C virus re-emergence after sustained virological response.
    J Med Virol. 2008;80:1720-1722.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. KUNTZEN T , Berical A, Ndjomou J, Bennett P, et al
    A set of reference sequences for the hepatitis C genotypes 4d, 4f, and 4k covering the full open reading frame.
    J Med Virol. 2008;80:1370-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
    Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
    J Med Virol. 2008;80:1363-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
    Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma.
    J Med Virol. 2008;80:1354-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. LIN A , Kadam JS, Bodenheimer HC, Leonard J, et al
    Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: A study of two cases.
    J Med Virol. 2008;80:1350-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. DIOP-NDIAYE H , Toure-Kane C, Etard JF, Lo G, et al
    Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    J Med Virol. 2008;80:1332-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2008
79. BARTOLOME J , Rodriguez-Inigo E, Quadros P, Vidal S, et al
    Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection.
    J Med Virol. 2008;80:1588-1594.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. YUN H , Kim D, Kim S, Kang S, et al
    High prevalence of HBV and HCV infection among intravenous drug users in Korea.
    J Med Virol. 2008;80:1570-1575.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. NICOT F , Legrand-Abravanel F, Lafont T, Dubois M, et al
    Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV.
    J Med Virol. 2008;80:1523-1529.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. RODRIGUEZ-TORRES M , Rios-Bedoya CF, Ortiz-Lasanta G, Purcell-Arevalo D, et al
    Weight affect relapse rates in latinos with genotype 2/3 chronic hepatitis C (CHC) treated with peg IFN alfa-2a (Pegasys) 180 mcg/week and 800 mg daily of ribavirin for 24 weeks.
    J Med Virol. 2008;80:1576-1580.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. SAGNELLI E , Imparato M, Coppola N, Pisapia R, et al
    Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: A multicenter study.
    J Med Virol. 2008;80:1547-1553.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. PARBOOSING R , Paruk I, Lalloo UG
    Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naive patients is associated with renal insufficiency and increased mortality.
    J Med Virol. 2008;80:1530-1536.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. NDONG-ATOME GR , Makuwa M, Ouwe-Missi-Oukem-Boyer O, Pybus OG, et al
    High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural gabon.
    J Med Virol. 2008;80:1581-1587.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. ARASE Y , Suzuki F, Suzuki Y, Akuta N, et al
    Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
    J Med Virol. 2008;80:1302-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
87. HOSSEINI-MOGHADDAM SM , Keyvani H, Samadi M, Alavian SM, et al
    GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus.
    J Med Virol. 2008;80:1260-1263.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. KAISER T , Damerow HC, Tenckhoff S, Finger A, et al
    Kinetics of hepatitis C viral RNA and HCV-antigen during dialysis sessions: Evidence for differential viral load reduction on dialysis.
    J Med Virol. 2008;80:1195-1201.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. XIA X , Lu L, Tee KK, Zhao W, et al
    The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China.
    J Med Virol. 2008;80:1142-1152.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
90. MIYAZAKI M , Kanto T, Inoue M, Itose I, et al
    Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    J Med Virol. 2008;80:980-988.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. CHENG PN , Wei YL, Chang TT, Chen JS, et al
    Therapy with interferon-alpha and ribavirin for chronic hepatitis C virus infection upregulates membrane HLA-ABC, CD86, and CD28 on peripheral blood mononuclear cells.
    J Med Virol. 2008;80:989-996.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. PARK SC , Jeong SH, Kim J, Han CJ, et al
    High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin's lymphoma in Korea.
    J Med Virol. 2008;80:960-966.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. VITALE F , Tramuto F, Orlando A, Vizzini G, et al
    Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    J Med Virol. 2008;80:577-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
94. MARTIN C , Nielsen SU, Ibrahim S, Bassendine MF, et al
    Binding of liver derived, low density hepatitis C virus to human hepatoma cells.
    J Med Virol. 2008;80:816-823.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. THONGSAWAT S , Maneekarn N, Kuniholm MH, Pantip C, et al
    Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand.
    J Med Virol. 2008;80:808-815.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. CARLSSON T , Quist A, Weiland O
    Rapid viral response and treatment outcome in genotype 2 and 3 chronic hepatitis C: comparison between two HCV RNA quantitation methods.
    J Med Virol. 2008;80:803-807.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. MICHOS A , Terzidis A, Kalampoki V, Pantelakis K, et al
    Seroprevalence and risk factors for hepatitis A, B, and C among roma and non-roma children in a deprived area of Athens, Greece.
    J Med Virol. 2008;80:791-797.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. MUERHOFF AS , Gutierrez R, Kyrk C, Leary T, et al
    Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
    J Med Virol. 2008;80:411-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. QUARANTINI LC , Miranda-Scippa A, Batista-Neves S, Galvao-de-Almeida A, et al
    The effect of early virological response in health-related quality of life in HCV-infected patients.
    J Med Virol. 2008;80:419-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
100. NAKAMURA M , Saito H, Ikeda M, Tada S, et al
     Possible molecular mechanism of the relationship between NS5B polymorphisms and early clearance of hepatitis C virus during interferon plus ribavirin treatment.
     J Med Virol. 2008;80:632-639.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. DI LELLO F , Garcia G, Kott V, Sookoian S, et al
     Diversity of hepatitis C virus genotype 1b in Buenos Aires, Argentina: description of a new cluster associated with response to treatment.
     J Med Virol. 2008;80:619-627.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. MICALESSI MI , Gerard C, Ameye L, Plasschaert S, et al
     Distribution of hepatitis C virus genotypes among injecting drug users in contact with treatment centers in Belgium, 2004-2005.
     J Med Virol. 2008;80:640-645.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. PELLICANO R , Puglisi G, Ciancio A, Balzola F, et al
     Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
     J Med Virol. 2008;80:628-631.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. CHLABICZ S , Flisiak R, Kowalczuk O, Wiercinska-Drapalo A, et al
     High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in North-Eastern Poland.
     J Med Virol. 2008;80:615-618.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. BOUZGARROU N , Hassen E, Schvoerer E, Stoll-Keller F, et al
     Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection.
     J Med Virol. 2008;80:607-614.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. ALZAHRANI AJ
     Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
     J Med Virol. 2008;80:603-606.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2007
107. NASCIMENTO MC , Mayaud P, Sabino EC, Torres KL, et al
     Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: A multi-center serosurvey.
     J Med Virol. 2007;80:53-57.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: